Gail Holler - Innophos Holdings Vice President - Human Resources
President
Ms. Gail Holler is Vice President Human Resources of Innophos Holdings, Inc., since May 2011. Ms. Holler joined Innophos in December of 2010 as Senior Director Human Resources. She has 30 years of experience working in Human Resources for global as well as multinational organizations in both corporate and operational environments, including pharmaceutical, medical device, biotech, and IT companies. Prior to joining Innophos, Ms. Holler worked for Tata Consultancy Services, from May 2009 to December 2010. Previous to that, she was Vice President Human Resources for LifeCell. She also worked for SanofiAventis for 14 years, with her last position as Vice President Human Resources for the Global Dermatology Division since 2011.
| Age | 55 |
| Tenure | 13 years |
| Phone | 609 495-2495 |
| Web | www.innophos.com |
Innophos Holdings Management Efficiency
Innophos Holdings' management efficiency ratios could be used to measure how well Innophos Holdings manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 399.86 M in liabilities with Debt to Equity (D/E) ratio of 118.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Innophos Holdings has a current ratio of 2.88, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Innophos Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Innophos Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Innophos Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Innophos to invest in growth at high rates of return. When we think about Innophos Holdings' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Stephen Thompson | Boyd Gaming | 64 | |
| Greggory Kalvin | Dine Brands Global | 57 | |
| Daniel Olmo | Dine Brands Global | 41 | |
| Peter Farmakis | Jeld Wen Holding | 52 | |
| Darren Rebelez | Dine Brands Global | 52 | |
| Connie Collins | One Group Hospitality | N/A | |
| Anthony McDuffie | Boyd Gaming | 59 | |
| Ronald Palmese | Shake Shack | 36 | |
| Tony Moralejo | Dine Brands Global | 59 | |
| Allison Hall | Dine Brands Global | 59 | |
| Brooks Mallard | Jeld Wen Holding | 50 | |
| Tyler Loy | One Group Hospitality | 44 | |
| Timothy Craven | Jeld Wen Holding | 56 | |
| Laura Doerre | Jeld Wen Holding | 51 | |
| Brian Larson | Boyd Gaming | 62 | |
| Jay Johns | Dine Brands Global | 63 | |
| John Cywinski | Dine Brands Global | 61 | |
| Tara Comonte | Shake Shack | 45 | |
| Peter Maxwell | Jeld Wen Holding | 55 | |
| John Linker | Jeld Wen Holding | 45 | |
| Marianne Johnson | Boyd Gaming | 66 | |
Management Performance
| Return On Equity | 0.0014 | |||
| Return On Asset | 7.0E-4 |
Innophos Holdings Leadership Team
Elected by the shareholders, the Innophos Holdings' board of directors comprises two types of representatives: Innophos Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Innophos. The board's role is to monitor Innophos Holdings' management team and ensure that shareholders' interests are well served. Innophos Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Innophos Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Randolph Gress, Chairman, CEO and Pres | ||
| Eugenia Erlij, Vice President - Marketing | ||
| Kim Mink, CEO and President and Director | ||
| Abraham Shabot, Vice President Director General, Innophos Latin America | ||
| James Zallie, Independent Director | ||
| Peter Thomas, Director | ||
| Jean Mainente, Chief Human Resource Officer, Senior Vice President | ||
| William Dunworth, Chief Accounting Officer, Vice President Corporate Controller | ||
| Amado Cavazos, Independent Director | ||
| Nicolas Meyrial, Vice President - Commercial Nutrition | ||
| William Farran, Sr. VP, General Counsel and Member of Proxy Committee | ||
| Mark Thurston, Vice President - Corporate Strategy and Worldwide Business Development | ||
| Mark Feuerbach, Sr. VP of Investor Relations, Treasury, Financial Planning and Analysis | ||
| Mark Santangelo, Senior Vice President - Manufacturing, Engineering and EH&S | ||
| Gary Cappeline, Lead Independent Director | ||
| Susan Turner, Vice President - Quality & Regulatory | ||
| Yasef Murat, Senior Vice President - Global Manufacturing | ||
| Hermanus Kieftenbeld, CFO, Senior Vice President | ||
| Linda Myrick, Independent Director | ||
| Amy Hartzell, Vice President - Supply Chain and Purchasing | ||
| Sherry Duff, Chief Marketing Officer, Vice President | ||
| Gail Holler, Vice President - Human Resources | ||
| Joshua Horenstein, Acting Chief Legal Officer and Corporate Secretary | ||
| Jane Hilk, Director | ||
| Louis Calvarin, Chief Risk Officer and Sr. VP of Strategy | ||
| Robert Sklans, Chief Human Resource Officer, Senior Vice President | ||
| Joseph Golowski, Sr. VP of Global Specialty Phosphates | ||
| Charles Brodheim, Vice President Corporate Controller | ||
| Karen Osar, Independent Director | ||
| John Steitz, Independent Director | ||
| Robert Zatta, Director |
Innophos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Innophos Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0014 | |||
| Return On Asset | 7.0E-4 | |||
| Profit Margin | 0.0006 % | |||
| Operating Margin | 14.40 % | |||
| Current Valuation | 993.69 M | |||
| Shares Outstanding | 19.69 M | |||
| Shares Owned By Insiders | 1.36 % | |||
| Shares Owned By Institutions | 98.64 % | |||
| Number Of Shares Shorted | 187.27 K | |||
| Price To Earning | 29.65 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Innophos Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Innophos Holdings' short interest history, or implied volatility extrapolated from Innophos Holdings options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Innophos Holdings information on this page should be used as a complementary analysis to other Innophos Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Innophos Stock
If you are still planning to invest in Innophos Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Innophos Holdings' history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |